Pfizer's 2021 profits doubled to US$22 bn on strong Covid vaccine sales

Pfizer's 2021 profits doubled to US bn on strong Covid vaccine sales

NEW YORK: Pfizer forecast more than US$50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the giant pharma company reported a more than doubling of annual profits on strong vaccine sales.

© New Straits Times Press (M) Bhd

Scroll to Top